Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness

被引:0
|
作者
Derjung M. Tarn
Kevin J. Shih
Allison J. Ober
Sarah B. Hunter
Katherine E. Watkins
Jeremy Martinez
Alanna Montero
Michael McCreary
Isabel Leamon
John Sheehe
Elizabeth Bromley
机构
[1] University of California,Department of Family Medicine
[2] Los Angeles,Department of Psychiatry and Biobehavioral Sciences
[3] RAND Corporation,Department of Family Medicine
[4] LA County Department of Mental Health,undefined
[5] University of California,undefined
[6] Los Angeles,undefined
[7] David Geffen School of Medicine at UCLA,undefined
来源
Community Mental Health Journal | 2023年 / 59卷
关键词
Mental disorders; Opioid use disorders; Opioid-related disorders; Narcotic antagonists; Buprenorphine-naloxone drug combination; Qualitative research;
D O I
暂无
中图分类号
学科分类号
摘要
Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as “cheating”. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.
引用
收藏
页码:345 / 356
页数:11
相关论文
共 50 条
  • [1] Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
    Tarn, Derjung M.
    Shih, Kevin J.
    Ober, Allison J.
    Hunter, Sarah B.
    Watkins, Katherine E.
    Martinez, Jeremy
    Montero, Alanna
    McCreary, Michael
    Leamon, Isabel
    Sheehe, John
    Bromley, Elizabeth
    COMMUNITY MENTAL HEALTH JOURNAL, 2023, 59 (02) : 345 - 356
  • [2] Prescription opioid use among individuals with serious mental illness
    Spivak, Stanislav
    Cullen, Bernadette
    Eaton, William
    Nugent, Katie
    Spivak, Amethyst
    Fenton, Ashley
    Rodriguez, Katrina
    Mojtabai, Ramin
    PSYCHIATRY RESEARCH, 2018, 267 : 85 - 87
  • [3] Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches
    Suzuki, Joji
    Loguidice, Frank
    Martin, Bianca
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (01) : 101 - 103
  • [4] Prevalence of Opioid Use Disorder and Opioid Overdose Rates Among People With Mental Illness
    Chen, Qingxian
    Gopaldas, Manesh
    Castillo, Felipe
    Leckman-Westin, Emily
    Nunes, Edward V.
    Levin, Frances R.
    Finnerty, Molly T.
    PSYCHIATRIC SERVICES, 2024, 75 (10) : 953 - 960
  • [5] Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis
    Bromley, Elizabeth
    Tarn, Derjung M.
    McCreary, Michael
    Hurley, Brian
    Ober, Allison J.
    Watkins, Katherine E.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 114
  • [6] Antagonist opioid medications in mental illness: State of art and future perspectives
    Maremmani, Icro
    Rovai, Luca
    Maremmani, Angelo Giovanni Icro
    Bacciardi, Silvia
    Rugani, Fabio
    Massimetti, Enrico
    Gazzarrini, Denise
    Pallucchini, Alessandro
    Janiri, Luigi
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2015, 17 (04) : 9 - 67
  • [7] The receipt of medications for opioid use disorder among pregnant individuals in the USA: a multilevel analysis
    Curran, Laura
    Manuel, Jennifer
    DRUGS HABITS AND SOCIAL POLICY, 2024, 25 (01): : 51 - 66
  • [8] Hedonic capacity in individuals treated with medications for Opioid Use Disorder
    Wenzel, Kevin
    Thomas, Julia
    Carrano, Jennifer
    Severino, Amie
    Fishman, Marc
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2022, 24 (05) : 37 - 41
  • [9] The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder
    Friesen, Erik Loewen
    Kurdyak, Paul
    DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [10] Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
    Lisa B. Puglisi
    Precious S. Bedell
    Anna Steiner
    Emily A. Wang
    Current Addiction Reports, 2019, 6 : 365 - 373